Success Metrics

Clinical Success Rate
100.0%

Based on 5 completed trials

Completion Rate
100%(5/5)
Active Trials
1(17%)
Results Posted
40%(2 trials)

Phase Distribution

Ph not_applicable
4
67%

Phase Distribution

0

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution4 total trials
N/ANon-phased studies
4(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

100.0%

5 of 5 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

1

trials recruiting

Total Trials

6

all time

Status Distribution
Active(1)
Completed(5)

Detailed Status

Completed5
Active, not recruiting1

Development Timeline

Analytics

Development Status

Total Trials
6
Active
1
Success Rate
100.0%
Most Advanced
N/A

Trials by Phase

N/A4 (100.0%)

Trials by Status

completed583%
active_not_recruiting117%

Recent Activity

1 active trials
Showing 5 of 6
completednot_applicable

Randomized Comparison of DCB for the Treatment of Superficial Femoral and Popliteal Peripheral Artery Disease

NCT02648334
active_not_recruitingnot_applicable

The Chocolate Touch Study

NCT02924857
completednot_applicable

LEVANT 2 Safety Registry

NCT01790243
completednot_applicable

LEVANT 2 Continuation Registry of the Lutonix® Drug Coated Balloon (DCB)

NCT01628159
completed

Bard LifeStent and Lutonix DCB for Treatment of Long Lesions in Femoropopliteal Arteries

NCT02278991
View all 6 trials

Clinical Trials (6)

Showing 6 of 6 trials
NCT02648334Not Applicable

Randomized Comparison of DCB for the Treatment of Superficial Femoral and Popliteal Peripheral Artery Disease

Completed
NCT02924857Not Applicable

The Chocolate Touch Study

Active Not Recruiting
NCT01790243Not Applicable

LEVANT 2 Safety Registry

Completed
NCT01628159Not Applicable

LEVANT 2 Continuation Registry of the Lutonix® Drug Coated Balloon (DCB)

Completed
NCT02278991

Bard LifeStent and Lutonix DCB for Treatment of Long Lesions in Femoropopliteal Arteries

Completed
NCT01864278

Lutonix Global SFA Registry

Completed

All 6 trials loaded

Drug Details

Intervention Type
DEVICE
Total Trials
6